Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.6 USD | +2.70% | +5.06% | +34.30% |
Apr. 19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
Apr. 01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.30% | 2.32B | |
+12.68% | 3,096B | |
+12.77% | 85.37B | |
+7.93% | 77.1B | |
-13.71% | 54.31B | |
-22.31% | 47.92B | |
+25.86% | 47.74B | |
+25.42% | 42.15B | |
+70.12% | 38.06B | |
-8.46% | 24.73B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Earnings Flash (CLBT) CELLEBRITE DI Reports Q2 Revenue $76.7M, vs. Street Est of $72.5M